Cargando…

Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy

OBJECTIVE: To evaluate the association of patient-reported severity of painful diabetic peripheral neuropathy (pDPN) with other outcomes in a European population of patients using the Adelphi Disease Specific Programme for pDPN (DSP III, 2008). METHODS: The severity of patients’ pDPN (mild, moderate...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor-Stokes, Gavin, Pike, James, Sadosky, Alesia, Chandran, Arthi, Toelle, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257968/
https://www.ncbi.nlm.nih.gov/pubmed/22253538
http://dx.doi.org/10.2147/DMSO.S27455
_version_ 1782221219426205696
author Taylor-Stokes, Gavin
Pike, James
Sadosky, Alesia
Chandran, Arthi
Toelle, Thomas
author_facet Taylor-Stokes, Gavin
Pike, James
Sadosky, Alesia
Chandran, Arthi
Toelle, Thomas
author_sort Taylor-Stokes, Gavin
collection PubMed
description OBJECTIVE: To evaluate the association of patient-reported severity of painful diabetic peripheral neuropathy (pDPN) with other outcomes in a European population of patients using the Adelphi Disease Specific Programme for pDPN (DSP III, 2008). METHODS: The severity of patients’ pDPN (mild, moderate, or severe) was rated independently by both patients and physicians. Relationships were evaluated between patient-reported pDPN severity and other patient-reported outcomes including pain, sleep, function, and work productivity. Physicians rated the severity of patients’ pDPN (1 = mild, 2 = moderate, 3 = severe) and sleep interference. RESULTS: Patient-reported data were available from 634 individuals (56.2% male, mean age 63 years) from France, Germany, Italy, and the UK, of whom only 22.2% reported that they were currently employed. pDPN severity was rated as mild, moderate, and severe by 22.2%, 60.9%, and 16.9% of the patients, respectively. There was a significant association between patient-rated and physician-rated pDPN severity (P < 0.0001), although there were discrepancies in agreement (kappa = 0.37, 95% confidence interval [CI] 0.31, 0.43; weighted kappa = 0.43, 95% CI 0.37, 0.48) among physician and patient ratings in a substantial proportion of patients across severity categories. Higher pDPN severity was associated with greater interference of daily function including sleep (P < 0.0001 for all pairwise comparisons). Among employed patients, percent of pDPN-related impairment while at work (presenteeism) and overall work impairment increased with greater pDPN severity, resulting in indirect costs that increased significantly with pDPN severity; $8266, $15,449, and $24,300 for mild, moderate, and severe pDPN, respectively (overall P < 0.001). CONCLUSION: Severity of patient-rated pDPN was significantly associated with outcomes, including function and productivity; poorer function and lower productivity were reported at higher pDPN severity levels. Moreover, physicians rated pDPN severity different from patients in a substantial proportion of patients.
format Online
Article
Text
id pubmed-3257968
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-32579682012-01-17 Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy Taylor-Stokes, Gavin Pike, James Sadosky, Alesia Chandran, Arthi Toelle, Thomas Diabetes Metab Syndr Obes Original Research OBJECTIVE: To evaluate the association of patient-reported severity of painful diabetic peripheral neuropathy (pDPN) with other outcomes in a European population of patients using the Adelphi Disease Specific Programme for pDPN (DSP III, 2008). METHODS: The severity of patients’ pDPN (mild, moderate, or severe) was rated independently by both patients and physicians. Relationships were evaluated between patient-reported pDPN severity and other patient-reported outcomes including pain, sleep, function, and work productivity. Physicians rated the severity of patients’ pDPN (1 = mild, 2 = moderate, 3 = severe) and sleep interference. RESULTS: Patient-reported data were available from 634 individuals (56.2% male, mean age 63 years) from France, Germany, Italy, and the UK, of whom only 22.2% reported that they were currently employed. pDPN severity was rated as mild, moderate, and severe by 22.2%, 60.9%, and 16.9% of the patients, respectively. There was a significant association between patient-rated and physician-rated pDPN severity (P < 0.0001), although there were discrepancies in agreement (kappa = 0.37, 95% confidence interval [CI] 0.31, 0.43; weighted kappa = 0.43, 95% CI 0.37, 0.48) among physician and patient ratings in a substantial proportion of patients across severity categories. Higher pDPN severity was associated with greater interference of daily function including sleep (P < 0.0001 for all pairwise comparisons). Among employed patients, percent of pDPN-related impairment while at work (presenteeism) and overall work impairment increased with greater pDPN severity, resulting in indirect costs that increased significantly with pDPN severity; $8266, $15,449, and $24,300 for mild, moderate, and severe pDPN, respectively (overall P < 0.001). CONCLUSION: Severity of patient-rated pDPN was significantly associated with outcomes, including function and productivity; poorer function and lower productivity were reported at higher pDPN severity levels. Moreover, physicians rated pDPN severity different from patients in a substantial proportion of patients. Dove Medical Press 2011-12-05 /pmc/articles/PMC3257968/ /pubmed/22253538 http://dx.doi.org/10.2147/DMSO.S27455 Text en © 2011 Taylor-Stokes et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Taylor-Stokes, Gavin
Pike, James
Sadosky, Alesia
Chandran, Arthi
Toelle, Thomas
Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy
title Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy
title_full Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy
title_fullStr Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy
title_full_unstemmed Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy
title_short Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy
title_sort association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257968/
https://www.ncbi.nlm.nih.gov/pubmed/22253538
http://dx.doi.org/10.2147/DMSO.S27455
work_keys_str_mv AT taylorstokesgavin associationofpatientratedseveritywithotheroutcomesinpatientswithpainfuldiabeticperipheralneuropathy
AT pikejames associationofpatientratedseveritywithotheroutcomesinpatientswithpainfuldiabeticperipheralneuropathy
AT sadoskyalesia associationofpatientratedseveritywithotheroutcomesinpatientswithpainfuldiabeticperipheralneuropathy
AT chandranarthi associationofpatientratedseveritywithotheroutcomesinpatientswithpainfuldiabeticperipheralneuropathy
AT toellethomas associationofpatientratedseveritywithotheroutcomesinpatientswithpainfuldiabeticperipheralneuropathy